Diagnostic Imaging's Weekly Scan: November 30 — December 6

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

There was a fair amount of new breast imaging research presented at the RSNA conference this week. Prior to the conference, Stamatia Destounis, M.D., discussed new research from a retrospective study involving 1,290 women with nearly 1,800 cases of breast cancer. Dr. Destounis and her colleagues found that over 20 percent of breast cancer was detected in women under 50 years of age and that 80 percent of these cases involved invasive breast cancer.

In another study presented at the RSNA conference, researchers found that the image-only AI model Clairity Breast offered more accurate assessment of five-year breast cancer risk than breast density alone.

Amid a bevy of news about new and emerging products at RSNA, Philips introduced the BlueSeal Horizon device, which is reportedly the first MRI platform with a helium-free 3T magnet. The MRI system also offers a variety of AI-powered features as well as enhanced 3D image reconstruction.

In ultrasound research presented at the RSNA conference, researchers noted an array of vascular complications associated with cosmetic fillers, including absent flow to perforator vessels in the face that occurred in over 40 percent of the cohort.

Emerging coronary computed tomography angiography (CCTA) research, presented at RSNA, reveals that long-term exposure to the common air pollutants gaseous nitrogen oxide (NO2) and fine particulate matter (PM2.5) may be linked to higher risks for coronary artery stenosis and obstructive coronary artery disease (CAD).

Watch the video summary below of Diagnostic Imaging’s Weekly Scan.